BRPI0416226A - derivados do ácido fosfìnico - Google Patents

derivados do ácido fosfìnico

Info

Publication number
BRPI0416226A
BRPI0416226A BRPI0416226-9A BRPI0416226A BRPI0416226A BR PI0416226 A BRPI0416226 A BR PI0416226A BR PI0416226 A BRPI0416226 A BR PI0416226A BR PI0416226 A BRPI0416226 A BR PI0416226A
Authority
BR
Brazil
Prior art keywords
acid derivatives
phosphonic acid
pharmaceuticals
preparation
pharmaceutical compositions
Prior art date
Application number
BRPI0416226-9A
Other languages
English (en)
Inventor
Wolfgang Froestl
Original Assignee
Novartis Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Novartis Ag filed Critical Novartis Ag
Publication of BRPI0416226A publication Critical patent/BRPI0416226A/pt

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02—Phosphorus compounds
    • C07F9/28—Phosphorus compounds with one or more P—C bonds
    • C07F9/30—Phosphinic acids [R2P(=O)(OH)]; Thiophosphinic acids ; [R2P(=X1)(X2H) (X1, X2 are each independently O, S or Se)]
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02—Phosphorus compounds
    • C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
    • C07F9/553—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having one nitrogen atom as the only ring hetero atom
    • C07F9/576—Six-membered rings
    • C07F9/58—Pyridine rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/66—Phosphorus compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/08—Antiepileptics; Anticonvulsants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/08—Antiepileptics; Anticonvulsants
    • A61P25/10—Antiepileptics; Anticonvulsants for petit-mal
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/22—Anxiolytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Psychiatry (AREA)
  • Pain & Pain Management (AREA)
  • Hospice & Palliative Care (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Feed For Specific Animals (AREA)

Abstract

"DERIVADOS DO áCIDO FOSFìNICO". A presente invenção refere-se aos derivados do ácido fosfínico como antagonistas do GABA~ B~, sua preparação, seu uso como farmacêuticos e composições farmacêuticas contendo os mesmos.
BRPI0416226-9A 2003-11-21 2004-11-19 derivados do ácido fosfìnico BRPI0416226A (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB0327186.3A GB0327186D0 (en) 2003-11-21 2003-11-21 Organic compounds
PCT/EP2004/013177 WO2005054259A1 (en) 2003-11-21 2004-11-19 Phosphinic acid derivatives

Publications (1)

Publication Number Publication Date
BRPI0416226A true BRPI0416226A (pt) 2007-01-02

Family

ID=29764265

Family Applications (1)

Application Number Title Priority Date Filing Date
BRPI0416226-9A BRPI0416226A (pt) 2003-11-21 2004-11-19 derivados do ácido fosfìnico

Country Status (17)

Country Link
US (1) US7498319B2 (pt)
EP (1) EP1687319B1 (pt)
JP (1) JP4478156B2 (pt)
KR (1) KR100807894B1 (pt)
CN (1) CN1882598B (pt)
AT (1) ATE460421T1 (pt)
AU (1) AU2004295060B2 (pt)
BR (1) BRPI0416226A (pt)
CA (1) CA2545589C (pt)
DE (1) DE602004025965D1 (pt)
ES (1) ES2341254T3 (pt)
GB (1) GB0327186D0 (pt)
MX (1) MXPA06005704A (pt)
PL (1) PL1687319T3 (pt)
PT (1) PT1687319E (pt)
RU (1) RU2368616C2 (pt)
WO (1) WO2005054259A1 (pt)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN109125331A (zh) * 2018-09-13 2019-01-04 大连医科大学附属第二医院 Gabab受体拮抗剂在阻断trek-1通道方面的应用

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8820266D0 (en) * 1988-08-26 1988-09-28 Smith Kline French Lab Compounds
IL114631A (en) * 1990-06-22 1998-12-06 Novartis Ag Anti-epileptic compositions containing gabab- antagonistic compounds
EP0543780A3 (en) * 1991-11-21 1993-09-01 Ciba-Geigy Ag Novel aminoalkanephosphinic acids and their salts
AU662404B2 (en) * 1992-05-08 1995-08-31 Novartis Ag Novel N-aralkyl- and N-heteroaralkyl-aminoalkanephosphinic acids
SE9603408D0 (sv) * 1996-09-18 1996-09-18 Astra Ab Medical use

Also Published As

Publication number Publication date
CA2545589A1 (en) 2005-06-16
US20070259835A1 (en) 2007-11-08
RU2368616C2 (ru) 2009-09-27
CN1882598A (zh) 2006-12-20
ES2341254T3 (es) 2010-06-17
PT1687319E (pt) 2010-06-04
EP1687319A1 (en) 2006-08-09
CA2545589C (en) 2013-03-12
EP1687319B1 (en) 2010-03-10
RU2006121648A (ru) 2008-01-10
GB0327186D0 (en) 2003-12-24
CN1882598B (zh) 2010-06-16
ATE460421T1 (de) 2010-03-15
AU2004295060A1 (en) 2005-06-16
KR100807894B1 (ko) 2008-02-27
US7498319B2 (en) 2009-03-03
PL1687319T3 (pl) 2010-08-31
KR20060097037A (ko) 2006-09-13
AU2004295060B2 (en) 2007-08-30
MXPA06005704A (es) 2006-08-17
JP2007513088A (ja) 2007-05-24
JP4478156B2 (ja) 2010-06-09
DE602004025965D1 (en) 2010-04-22
WO2005054259A1 (en) 2005-06-16

Similar Documents

Publication Publication Date Title
SE0301010D0 (sv) Novel compounds
SE0301009D0 (sv) Novel compounds
SE0301700D0 (sv) Novel compounds
CY1109369T1 (el) Υποκατεστημενες πυρρολοπυριδινες, οι ενωσεις που τις περιεχουν, η διαδικασια παρασκευης τους και η χρηση τους
CY1112721T1 (el) Νεοι συνδετες που διαμορφωνουν τους υποδοχεις rαr, και χρηση αυτων στην ιατρικη για τον ανθρωπο και στα καλλυντικα
SE0101675D0 (sv) Novel composition
EA200501268A1 (ru) Ингибирующие вич 1,2,4-триазины
MXPA05012025A (es) Imidazo y tiazolopiridinas como inhibidores de cinasa jak3.
ATE362932T1 (de) Azaindolverbindungen als kinaseinhibitoren
ATE486587T1 (de) Formulierungen zur oralen verabreichung von wirkstoffen
JO2515B1 (en) Gamma-Crystalline form of ivabradine hydrochloride,a process for its preparation and pharmaceutical composition containing it
UA86591C2 (ru) Пирролодигидроизохинолины как ингибиторы pde10, фармацевтическая композиция на их основе
ATE332301T1 (de) Antivirale pyrazolopyridin verbindungen
TNSN04250A1 (en) Diphenyl azetidinones substituted by acidic groups, method for their production, medicaments containing said compounds and use thereof.
PA8575601A1 (es) Procedimiento para su preparacion, medicamentos que comprenden estos compuestos y su uso
EA200401526A1 (ru) Новые соединения и их применение
PT1791571E (pt) Péptidos radiofluorados
NO20063062L (no) Imidazolderivater, fremgangsmate for fremstilling og anvendelse av disse
EA200702589A1 (ru) 2,6-хинолинильные производные, способы их получения и их применение
MX2009000768A (es) Lactamas macrociclicas.
BRPI0408848A8 (pt) Composições farmacêuticas de complexo de ciclodextrina-cladribina complexo, usos do referido complexo, bem como processos para a sua preparação
CY1105039T1 (el) ΥΠΟΚΑΤΕΣΤΗΜΕΝΕΣ ΕΝΩΣΕΙΣ ΒΕΝΖΟ[b]ΑΖΕΠΙΝ-2-ΟΝΗΣ
EA200702375A1 (ru) Производные мочевины, способы их получения и применения
EA200701172A1 (ru) 2-алкокси-3,4,5-тригидроксиалкиламиды, их получение, композиции, их содержащие, и применение
SE0300457D0 (sv) Novel compounds

Legal Events

Date Code Title Description
B08F Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette]

Free format text: REFERENTE A 12A ANUIDADE.

B08K Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette]

Free format text: EM VIRTUDE DO ARQUIVAMENTO PUBLICADO NA RPI 2386 DE 27-09-2016 E CONSIDERANDO AUSENCIA DE MANIFESTACAO DENTRO DOS PRAZOS LEGAIS, INFORMO QUE CABE SER MANTIDO O ARQUIVAMENTO DO PEDIDO DE PATENTE, CONFORME O DISPOSTO NO ARTIGO 12, DA RESOLUCAO 113/2013.